FDA Inspection 1194475 — Department of Defense - Navy
The FDA completed an inspection of Department of Defense - Navy on December 9, 2022 in North Chicago, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 9, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- North Chicago, IL (United States)